Neoadjuvant Botensilimab/Balstilimab for localized mismatch repair proficient and deficient colon cancer: Results of the NEST phase 2 clinical trial - Manish A. Shah; Erika Hissong; Mehraneh D. Jafari; Pashtoon Murtaza. Kasi; Maider Astorkia; Sahrish Khan; Casey Owens; Zhengming Chen; Heather Yeo; Fabio Socciarelli; Sandipto Sarkar; Alana Nguyen; et al. (Clinical Cancer Research, 2026)